The company should benefit from capacity expansion and a deal to boost its position in the US and Europe
Thursday 12 Sep 2019 Author: Yoosof Farah
Chemicals firm Synthomer ( SYNT ) looks very tempting at the current price following a big sell-off over the past year. The firm’s share price dropped from around 530p a year ago to 280p last month and saw the stock trade on nearly its lowest rating in a decade, while its level of debt compared to how much it’s earning is expected to double. But with the business on...